Published studies dealing with the relationship between circulating le
vels of testosterone and dehydroepiandrosterone (sulfate) (DHEA(S)) an
d coronary heart disease (CHD) in males, as well as corresponding expe
rimental animal studies are reviewed. One randomized intervention stud
y, eight prospective and 30 cross-sectional studies have evaluated thi
s relationship. In the intervention study, testosterone undecanoate gi
ven orally significantly improved angina pectoris in 62 patients with
CHD as compared to placebo. No significant association between serum t
estosterone and CHD was reported in the prospective studies, whereas t
hose studies concerning DHEAS found either no or an inverse associatio
n with CHD. Of 30 cross-sectional studies, 18 reported reduced concent
rations of testosterone (primarily), and/or DHEA(S) in CHD patients as
compared to normals, 11 found similar circulating levels of these and
rogens in controls and patients with CHD, and one study found elevated
levels of DHEA(S) in patients. Animal studies (six in male rabbits an
d one in male chicks) suggest an anti-atherogenic effect of testostero
ne and DHEA. In conclusion, one intervention, eight cohort and several
cross-sectional studies suggest either a neutral or a favourable effe
ct of testosterone and DHEA(S) on CHD in males.